This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ulmer, A J Articles by Flad, H D Search for Related Content PubMed PubMed Citation Articles by Ulmer, A J Articles by Flad, H D

 Previous Article  |  Next Article 

Infect Immun. 1992 August; 60(8): 3309-3314

Biological activity of synthetic phosphonooxyethyl analogs of lipid A and lipid A partial structures.

Department of Immunology and Cell Biology, Forschungsinstitut Borstel, Germany.

ABSTRACT

We investigated the biological activity of four new synthetic analogs of lipid A, termed PE-1, PE-2, PE-3, and PE-4. All compounds contain an alpha-oxyethyl-linked (-O-CH2-CH2-) phosphoryl group in position 1 of the reducing glucosaminyl residue (GlcN I) of lipid A. PE-1 is a hexaacylated analog of Escherichia coli lipid A (compound 506). PE-2 differs from PE-1 in carrying two myristic acid residues at GlcN I. PE-3 has the same acylation pattern as PE-2, but GlcN I is present in the beta anomeric form. Finally, PE-4 represents an analog of tetraacyl precursor Ia (compound 406). Structure-activity relationships of these compounds were determined by measuring their capacity to induce tumor necrosis factor alpha, interleukin 1, and interleukin 6 release by human mononuclear cells and to cause mitogenicity of murine spleen cells. The results show that replacement of the glycosidic phosphoryl residue by a phosphonooxyethyl group had no substantial effect on the biological activity of compounds. However, the anomeric configuration of GlcN I was found to be of great biological relevance, as, in general, the alpha anomer (PE-2) expressed high activity, and the beta anomer (PE-3) expressed low mediator-inducing and mitogenic activity. The absence of the 3-hydroxyl groups within the acyl residues at GlcN I in PE-2 was found to only slightly affect the induction of monokines in human mononuclear cells compared with that of PE-1 or lipid A (506). These stable 1-phosphonooxyethyl analogs of lipid A may be candidates in the development of immunomodulators for the treatment of systemic endotoxicosis.

This article has been cited by other articles:

• Buwitt-Beckmann, U., Heine, H., Wiesmuller, K.-H., Jung, G., Brock, R., Akira, S., Ulmer, A. J. (2006). TLR1- and TLR6-independent Recognition of Bacterial Lipopeptides. J. Biol. Chem. 281: 9049-9057 [Abstract] [Full Text]  
• Matsuura, M., Kiso, M., Hasegawa, A. (1999). Activity of Monosaccharide Lipid A Analogues in Human Monocytic Cells as Agonists or Antagonists of Bacterial Lipopolysaccharide. Infect. Immun. 67: 6286-6292 [Abstract] [Full Text]  
• Fukase, K., Oikawa, M., Suda, Y., Liu, W.-C., Fukase, Y., Shintaku, T., Sekljic, H., Yoshizaki, H., Kusumoto, S. (1999). New synthesis and conformational analysis of lipid A: biological activity and supramolecular assembly. Innate Immunity 5: 46-51 [Abstract]  
• Kitchens, R. L., Munford, R. S. (1995). Enzymatically Deacylated Lipopolysaccharide (LPS) Can Antagonize LPS at Multiple Sites in the LPS Recognition Pathway. J. Biol. Chem. 270: 9904-9910 [Abstract] [Full Text]  
• Heine, H., Brade, H., Kusumoto, S., Kusama, T., Rietschel, E. Th., Flad, H.-D., Ulmer, A.J. (1994). Inhibition of LPS binding on human monocytes by phosphonooxyethyl analogs of lipid A. Innate Immunity 1: 14-20 [Abstract]